Novel ocular immunotherapy induces tumor regression in an equine model of ocular surface squamous neoplasia.

[1]  P. Hegyi,et al.  Topical pharmacotherapy for ocular surface squamous neoplasia: systematic review and meta-analysis , 2022, Scientific Reports.

[2]  yang-xin fu,et al.  Next generation of tumor-activating type I IFN enhances anti-tumor immune responses to overcome therapy resistance , 2021, Nature Communications.

[3]  Zhijie Li,et al.  Resident Innate Immune Cells in the Cornea , 2021, Frontiers in Immunology.

[4]  D. Brooks,et al.  Opposing Roles of Type I Interferons in Cancer Immunity. , 2020, Annual review of pathology.

[5]  R. Bellone,et al.  DDB2 Genetic Risk Factor for Ocular Squamous Cell Carcinoma Identified in Three Additional Horse Breeds , 2020, Genes.

[6]  P. Reddell,et al.  Use of the Intratumoural Anticancer Drug Tigilanol Tiglate in Two Horses , 2020, Frontiers in Veterinary Science.

[7]  R. Bellone.  Genetics of Equine Ocular Disease. , 2020, The Veterinary clinics of North America. Equine practice.

[8]  W. Wheat,et al.  Non-specific protection from respiratory tract infections in cattle generated by intranasal administration of an innate immune stimulant , 2020, PloS one.

[9]  A. Green,et al.  Molecular Aspects and Future Perspectives of Cytokine-Based Anti-cancer Immunotherapy , 2020, Frontiers in Cell and Developmental Biology.

[10]  F. Belardelli,et al.  Type I Interferons and Cancer: An Evolving Story Demanding Novel Clinical Applications , 2019, Cancers.

[11]  W. Wheat,et al.  Local immune and microbiological responses to mucosal administration of a Liposome-TLR agonist immunotherapeutic in dogs , 2019, BMC Veterinary Research.

[12]  A. Galor,et al.  Update on pharmacotherapy for ocular surface squamous neoplasia , 2019, Eye and Vision.

[13]  W. Wheat,et al.  Activation of upper respiratory tract mucosal innate immune responses in cats by liposomal toll‐like receptor ligand complexes delivered topically , 2019, Journal of veterinary internal medicine.

[14]  Yaping Li,et al.  Overview of recent advances in liposomal nanoparticle-based cancer immunotherapy , 2019, Acta Pharmacologica Sinica.

[15]  M. Singer-Berk,et al.  A missense mutation in damage-specific DNA binding protein 2 is a genetic risk factor for ocular squamous cell carcinoma in Belgian horses. , 2019, Equine veterinary journal.

[16]  R. Dubielzig,et al.  Canine, feline, and equine corneal vascular neoplasia: A retrospective study (2007‐2015) , 2019, Veterinary ophthalmology.

[17]  R. Dolcetti,et al.  Plasticity of Type I Interferon-Mediated Responses in Cancer Therapy: From Anti-tumor Immunity to Resistance , 2018, Front. Oncol..

[18]  K. Estell.  Periocular Neoplasia in the Horse. , 2017, The Veterinary clinics of North America. Equine practice.

[19]  C. Murphy,et al.  The SPOTS System: An Ocular Scoring System Optimized for Use in Modern Preclinical Drug Development and Toxicology. , 2017, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[20]  J. Petersen,et al.  A missense mutation in damage‐specific DNA binding protein 2 is a genetic risk factor for limbal squamous cell carcinoma in horses , 2017, International journal of cancer.

[21]  S. Brandt,et al.  Papillomavirus infection and squamous cell carcinoma in horses. , 2017, Veterinary journal.

[22]  O. Tsitsilonis,et al.  Harnessing the immune system to improve cancer therapy. , 2016, Annals of translational medicine.

[23]  S. Dow,et al.  Manipulation of Innate Immunity for Cancer Therapy in Dogs , 2015, Veterinary sciences.

[24]  A. Gaynor,et al.  Equine Genital Squamous Cell Carcinoma , 2015, Veterinary pathology.

[25]  M. Burton,et al.  Pathophysiology of ocular surface squamous neoplasia , 2014, Experimental eye research.

[26]  S. Dow,et al.  Mucosal immunization with liposome-nucleic acid adjuvants generates effective humoral and cellular immunity. , 2011, Vaccine.

[27]  A. Galor,et al.  Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study , 2009, British Journal of Ophthalmology.

[28]  R. Dubielzig,et al.  Corneal stromal invasive squamous cell carcinoma: a retrospective morphological description in 10 horses. , 2009, Veterinary ophthalmology.

[29]  S. Dow,et al.  Liposome–nucleic acid immunotherapeutics , 2008, Expert opinion on drug delivery.

[30]  B. Njaa,et al.  Cyclooxygenase-2 Immunoreactivity in Equine Ocular Squamous-Cell Carcinoma , 2007, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[31]  J. Turk,et al.  Immunohistochemical evaluation of cyclooxygenase expression in corneal squamous cell carcinoma in horses. , 2007, American journal of veterinary research.

[32]  A. Blikslager,et al.  Expression of cyclooxygenase-1 and -2 in naturally occurring squamous cell carcinomas in horses. , 2007, American journal of veterinary research.

[33]  S. Dow,et al.  Efficient Immunization and Cross-Priming by Vaccine Adjuvants Containing TLR3 or TLR9 Agonists Complexed to Cationic Liposomes1 , 2006, The Journal of Immunology.

[34]  D. Liggitt,et al.  Liposome–DNA complexes infused intravenously inhibit tumor angiogenesis and elicit antitumor activity in dogs with soft tissue sarcoma , 2006, Cancer Gene Therapy.

[35]  D. Hendrix.  Equine Ocular Squamous Cell Carcinoma , 2005 .

[36]  A. Vidyashankar,et al.  Effects of treatment with and without adjuvant radiation therapy on recurrence of ocular and adnexal squamous cell carcinoma in horses: 157 cases (1985-2002). , 2004, Journal of the American Veterinary Medical Association.

[37]  J. Pascoe,et al.  Iridium-192 interstitial brachytherapy for equine periocular tumours: treatment results and prognostic factors in 115 horses. , 1995, Equine veterinary journal.

[38]  T. C. King,et al.  Therapeutic management of ocular squamous cell carcinoma in the horse: 43 cases (1979-1989). , 1991, Equine veterinary journal.

[39]  V. Lucke,et al.  Squamous cell carcinoma of the equine external genitalia: a review and assessment of penile amputation and urethrostomy as a surgical treatment. , 1991, Equine veterinary journal.

[40]  F. Blodi,et al.  Ocular tumors in domestic animals. , 1967, American journal of ophthalmology.